1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: None of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted , modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the fiscal quarter ended June 30, 2024.
+Added: None of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted , modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the fiscal quarter ended September 30, 2024.
Exhibit Number Description
1 unchanged sentence
001-40367) filed with the Securities and Exchange Commission on May 10, 2021)
+Added: Service Agreemen t with Leon Hooftman, effective February 21, 2024
31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 unchanged sentences
* Filed herewith.
+Added: # Indicates a management contract or any compensatory plan, contract or arrangement.
** This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section.
2 unchanged sentences
BARINTHUS BIOTHERAPEUTICS PLC
−Removed: August 8, 2024
+Added: November 6, 2024
/s/ William Enright
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 8, 2024
+Added: November 6, 2024
/s/ Gemma Brown
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.